JUMP TO CONTENT

What are the four phases of a clinical trial?

Posting date: 22/05/2022
Author: Inside ICON

Having enjoyed steady growth over the last several years, it’s predicted that the global clinical trials market will hit a value of $65.2 billion by 2025, and around 58% of this can be attributed to research within oncology. This is being driven by an increased demand for Clinical Research Organisations (CROs) to conduct clinical trials, a move towards personalised treatment and digitalisation of the healthcare market.

Despite the notable expansion of the market, it can take up to 15 years to get a new medicine or treatment to market because of the lengthy procedure of obtaining a licence. The process is split into distinct stages and each is thought of as a separate study where researchers are only permitted to move to the next stage once the U.S. Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA), European Medicines Agency (EMA) or other regulatory agency gives their approval. Here are the four phases of a clinical trial.

Phase I

Though there is sometimes a phase 0 to test whether researchers were correct about the way the body reacts to a drug, often clinical trials will start at phase I. A clinical trial refers to a study within clinical research where patients are monitored to determine the efficacy of a treatment; this can be a drug, medical device or procedure. Therefore, from the very first stage, a clinical operations team will be testing to see how the drug is broken down by the body, looking for side effects and beginning to find the optimal dosage.

Phase I ranges between several months to a year and tests the treatment on a small group of healthy patients. Once the trial is complete the drug safety associate (DSA) will submit their research to the regulatory agency at which point the FDA reports that around 7 in 10 receive approval.

Phase II

Those drugs, wearables or other treatments that pass approval at the first stage of clinical trials will progress to phase II where the focus is to test on a larger sample and typically introduce a placebo group. The placebo group - usually a randomised sample - will receive an inactive drug or a dummy treatment which allows clinical research associates (CRAs) to identify whether patients show side effects because they believe they’re receiving the treatment. Researchers can then compare the effectiveness of the treatment against the placebo group to get a clear picture of how well it works.

At this stage, clinical trial assistants (CTAs) are also assessing the safety of the treatment and monitoring any short-term adverse effects and phase II will normally span two years. The FDA reveals that the success rate at this stage is just 33%.

Phase III

At phase III, a clinical trial manager will work alongside the project manager to identify if the drug has an overall positive effect on the patient’s wellbeing. Having qualified to this stage CRO companies will recruit more patients into randomised groups to get a clearer picture of data discrepancies and therefore understand the success of the drug.

Treatments which receive approval after phase III are awarded a licence meaning that the medicine can go to market and be prescribed to the public. Over the last 10 years, US drug manufacturers have spent on average $1 billion getting their drug to market and this is partially due to rising costs associated with advancements in technology.

Read more on why you should be a project manager.

HTML Image as link


Phase IV

The fourth and final stage is tested once the drug has gone to market and is designed to understand the side effects better and establish if there are any long-term risks throughout the life span of the drug. At phase IV DSAs are evaluating the outcomes on a more wide-spread basis – generally in the thousands.

Work on some of the most exciting clinical trials with ICON

At ICON, we’re determined to be the partner of choice in drug development and this ambition sees us working on an extensive variety of projects. For more insight read about the impact of Covid-19 on pharmacovigilance.

Related Content

List #1

Related jobs at ICON

Clinical Trial Manager

Salary

Location

Brazil

Department

Clinical Trial Management

Location

Brazil

Remote Working

Remote

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

As a Clinical Trial Manager at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of treatments and t

Reference

2025-119104

Expiry date

01/01/0001

Bruna Duarte

Author

Bruna Duarte
Read more Shortlist Save this role
Clinical Risk Manager

Salary

Location

United States

Department

Clinical Trial Management

Location

United States

Remote Working

Remote

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Management

Job Type

Permanent

Description

ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us

Reference

2025-119282

Expiry date

01/01/0001

Jamie Pruitt

Author

Jamie Pruitt
Read more Shortlist Save this role
Customer Service Rep

Salary

Location

India, Chennai

Department

Full Service - Development & Commercialisation Solutions

Location

Chennai

Trivandrum

Remote Working

Office Based

Business Area

ICON Full Service & Corporate Support

Job Categories

Clinical Trial Support

Job Type

Permanent

Description

We are currently seeking a Customer Service Rep to join our diverse and dynamic team. As a Customer Service Rep at ICON, you will play a pivotal role in providing exceptional support to our clients an

Reference

JR129906

Expiry date

01/01/0001

Sunidhi Sinha

Author

Sunidhi Sinha
Read more Shortlist Save this role
CTA

Salary

Location

Brazil

Department

Clinical Operations Roles

Location

Brazil

Business Area

ICON Strategic Solutions

Job Categories

Clinical Trial Support

Job Type

Permanent

Description

As a CTA  you will be joining the world’s largest & most comprehensive clinical research organisation, powered by healthcare intelligence.

Reference

2025-116323

Expiry date

01/01/0001

Tulio Sanquiz

Author

Tulio Sanquiz
Read more Shortlist Save this role
View all
List #1

Related stories

Ovarian cancer knot being held in woman's hands
Standing Strong on Ovarian Cancer Day

Teaser label

Inside ICON

Content type

Blogs

Publish date

05/08/2025

Summary

Standing Strong on Ovarian Cancer Day:    ICON's Commitment to Advancing Care Ovarian cancer remains one of the most challenging gynaecologic malignancies, both in terms of detection and treatmen

Teaser label

Martin Lachs, VP, Oncology Project Management at ICON discusses ICON’s role in advancing ovarian cancer research.

Read more
Nurse and patient
Patient Centricity in Clinical Research

Teaser label

Industry

Content type

Blogs

Publish date

05/07/2025

Summary

Patient Centricity in Clinical Research: What it is and Why it Matters In the past, clinical research was designed around the needs of sponsors, researchers, and regulatory bodies. Patients were of

Teaser label

Discover how patient centricity is reshaping clinical research by placing participants at the heart of study design and execution.

Read more
Liquid capsules
Navigating Regulatory Landscapes - FDA, EMA, & MHRA

Teaser label

Industry

Content type

Blogs

Publish date

05/05/2025

Summary

Navigating Regulatory Landscapes:     Comparing FDA, EMA, & MHRA in Clinical Trials In clinical research, no matter how promising a new therapy may be, it will go nowhere without regulatory appro

Teaser label

Compare FDA, EMA, and MHRA regulatory frameworks for clinical trials, and why this knowledge matters.

Read more
View all
List #1

Recently viewed jobs

View Jobs

Browse popular job categories below or search all jobs above